No Breathing Room For Advair: GSK Combo Part Of Asthma Drug Restrictions

GlaxoSmithKline's asthma combination product Advair is included in an FDA advisory against first-line use of long-acting beta agonist bronchodilators despite an advisory committee review that suggested Advair was less risky than other products